DE69029145T2 - Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus - Google Patents

Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus

Info

Publication number
DE69029145T2
DE69029145T2 DE1990629145 DE69029145T DE69029145T2 DE 69029145 T2 DE69029145 T2 DE 69029145T2 DE 1990629145 DE1990629145 DE 1990629145 DE 69029145 T DE69029145 T DE 69029145T DE 69029145 T2 DE69029145 T2 DE 69029145T2
Authority
DE
Germany
Prior art keywords
virus
infectious disease
virus responsible
fabricius
bursa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1990629145
Other languages
English (en)
Other versions
DE69029145D1 (de
Inventor
David Snyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Application granted granted Critical
Publication of DE69029145D1 publication Critical patent/DE69029145D1/de
Publication of DE69029145T2 publication Critical patent/DE69029145T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A21D2/364—Nuts, e.g. cocoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE1990629145 1989-10-18 1990-09-27 Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus Expired - Fee Related DE69029145T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42375789A 1989-10-18 1989-10-18
PCT/US1990/005428 WO1991005569A1 (en) 1989-10-18 1990-09-27 Novel infectious bursal disease virus

Publications (2)

Publication Number Publication Date
DE69029145D1 DE69029145D1 (de) 1996-12-19
DE69029145T2 true DE69029145T2 (de) 1997-05-07

Family

ID=23680061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1990629145 Expired - Fee Related DE69029145T2 (de) 1989-10-18 1990-09-27 Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus

Country Status (10)

Country Link
EP (1) EP0496787B1 (de)
JP (1) JPH05504049A (de)
AT (1) ATE145236T1 (de)
AU (1) AU6605190A (de)
CA (1) CA2067397A1 (de)
DE (1) DE69029145T2 (de)
ES (1) ES2095258T3 (de)
NZ (1) NZ235474A (de)
WO (1) WO1991005569A1 (de)
ZA (1) ZA908260B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
EP0861665A1 (de) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Vakzine gegen Infektiöse Bursitis
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
EP1722814B1 (de) 2004-03-12 2016-11-09 Zoetis Services LLC Antigene isolate und vakzine des infektiösen bursitis-virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus

Also Published As

Publication number Publication date
WO1991005569A1 (en) 1991-05-02
DE69029145D1 (de) 1996-12-19
CA2067397A1 (en) 1991-04-19
JPH05504049A (ja) 1993-07-01
NZ235474A (en) 1992-12-23
EP0496787A4 (en) 1993-04-28
ZA908260B (en) 1991-08-28
ES2095258T3 (es) 1997-02-16
EP0496787A1 (de) 1992-08-05
ATE145236T1 (de) 1996-11-15
EP0496787B1 (de) 1996-11-13
AU6605190A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
ATE136788T1 (de) Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
SE9102975L (sv) Bakterofag och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ES2123558T3 (es) Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DE69029145T2 (de) Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
DE68920345D1 (de) Lebendes Kombinationsvakzin.
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.
DE3884672D1 (de) Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
FI972658A (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
KR920007636A (ko) 신규의 백신체
SE8701294D0 (sv) Hiv-peptid
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
DD129805A1 (de) Verfahren zur herstellung von viruslebendimpfstoffen,insbesondere aujeszky-lebendimpfstoff
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.
FI883765A (fi) Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee